Trevena to Release Second Quarter 2021 Financial Results on August 12th, 2021
Company to host conference call on Thursday, August 12th, 2021 at 8:00 a.m. ETCHESTERBROOK, Pa., Aug. 09, 2021 (GLOBE NEWSWIRE)...
Month: August 2021
Aravive Announces First Patient Dosed in Phase 1b/2 Clinical Trial of AVB-500 for the Treatment of Pancreatic Adenocarcinoma
Trial to Evaluate AVB-500 as a First-Line Treatment in Combination with Gemcitabine and Nab-Paclitaxel Continues Expansion of AVB-500 in Multiple...
Amryt Virtual Capital Markets Event – September 13, 2021 – 1000-1200 EDT
Amryt Virtual Capital Markets Event - September 13, 2021 – 1000-1200 EDT DUBLIN, Ireland, and Boston MA, August 9, 2021,...
Axsome Therapeutics Announces AXS-05 Achieves Primary and Key Secondary Endpoints in the MERIT Phase 2 Trial in Treatment Resistant Depression
AXS-05 significantly delayed the time to relapse of depression compared to placebo (p=0.002, primary endpoint) AXS-05 significantly prevented relapse of...
Algernon Pharmaceuticals Announces Exclusive Licensing Agreement with Dartmouth College
VANCOUVER, British Columbia, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or...
BioNTech Announces Second Quarter 2021 Financial Results and Corporate Update
More than one billion doses of BNT162b2 vaccine supplied to more than 100 countries or territories worldwide as of July...
Voyager Therapeutics Transforms Pipeline and Increases Investment in Next-Generation TRACER™ AAV Capsid and Vectorized Antibody Platform Technologies
Proprietary AAV capsids to power second-generation efforts in Huntington’s disease and ALS, pre-clinical programs in spinal muscular atrophy and diseases...
NervGen Pharma and Massachusetts General Hospital Collaborate on Preclinical Studies in Alzheimer’s Disease
Dr. Ksenia Kastanenka to Study NVG-291's Potential to Promote Repair in Alzheimer's Disease ModelsVancouver, British Columbia--(Newsfile Corp. - August 9,...
Halberd Corporation’s VITA-SHIELD-MAX(TM) Immunity Support Product Shipped
Jackson Center, Pennsylvania--(Newsfile Corp. - August 9, 2021) - Halberd Corporation (OTC Pink: HALB) reports Vita-Shield-MaxTM, has been shipped! With...
Cardiol Therapeutics to Commence Trading on NASDAQ Under the Symbol “CRDL”
Oakville, Ontario--(Newsfile Corp. - August 9, 2021) - Cardiol Therapeutics Inc. (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage biotechnology...
Nihon Kohden to Elevate Advancements Towards Improved Patient Outcomes with the Acquisition of Advanced Medical Predictive Devices, Diagnostics and Displays, Inc.
Striving to Connect Clinicians with Intelligent Devices and Continuous Data through Predictive Algorithms IRVINE, Calif.--(BUSINESS WIRE)--Nihon Kohden, a global leader...
Dalrada Health and Vivera Pharmaceuticals Announce New Diagnostic Laboratory Joint Venture
Pala Diagnostics, a CLIA-certified state-of-the-art diagnostic laboratory will provide laboratory mobile concierge service for businesses, conventions, hospitality, and schools to...
KORU Medical Systems to Participate in Canaccord Genuity’s 41st Annual Growth Conference
CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical...
Angle PLC – Study Highlights Superior Performance of Parsortix
PUBLICATION HIGHLIGHTS EASE OF USE AND SUPERIOR PERFORMANCE OF PARSORTIX SYSTEM IN HARVESTING CTCs FROM METASTATIC BREAST CANCER PATIENTSQuantity, purity...
RELIEF THERAPEUTICS Holdings AG: Acer Therapeutics and Relief Therapeutics Announce Submission of a New Drug Application to the U.S. FDA for ACER-001 for Treatment of Urea Cycle Disorders
NEWTON, MA and GENEVA, SWITZERLAND / ACCESSWIRE / August 9, 2021 / Acer Therapeutics Inc. (NASDAQ:ACER) (" Acer "), a...
Core One Labs to Move Its Psychedelic Formulations for the Treatment of Stroke and Depression Toward Clinical Development
VANCOUVER, British Columbia, Aug. 07, 2021 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABD), (Frankfurt: LD6, WKN:...
atai Life Sciences to Present at the 41st Annual Canaccord Genuity Growth Conference
BERLIN, Aug. 06, 2021 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to...
IBA – Regulated Information
IBA – ACQUISITION OF OWN SHARES Immediate Release – August 6th, 2021 Louvain-la-Neuve, Belgium, August 6th, 2021 - In accordance...
BioVie Inc. Announces Proposed Public Offering of Common Stock
SANTA MONICA, Calif., Aug. 06, 2021 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company...
Kids and Teen Dental Place and UCLA School of Dentistry Partner With Drew Child Development Corporation to Provide 1,000 Free Fluoride Treatments at Back to School Event on August 7th
LOS ANGELES, Aug. 06, 2021 (GLOBE NEWSWIRE) -- On August 7th, Kids Dental Place and the UCLA School of Dentistry...